conjugated estrogen
Conjugated estrogens (CEs), or conjugated equine estrogens (CEEs), sold under the brand name Premarin among others, is an estrogen medication which is used in menopausal hormone therapy and for various other indications. It is a mixture of the sodium salts of estrogen conjugates found in horses, such as estrone sulfate and equilin sulfate. CEEs are available in the form of both natural preparations manufactured from the urine of pregnant mares and fully synthetic replications of the natural preparations. They are formulated both alone and in combination with progestins such as medroxyprogesterone acetate. CEEs are usually taken by mouth, but can also be given by application to the skin or vagina as a cream or by injection into a blood vessel or muscle. — Wikipedia
Clinical trial activity
8 trials · 15 clinical orgs · 0 marketing orgs
Earliest trial started Jul 31, 2019 (NCT03996603)
Timeline
Indications
Approved for
Studied for
Mechanism of action
- Estrogen receptorAGONIST
Estrogen receptor agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaConjugated estrogens ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05073237 | Phase 2 | Jan 17, 2022 | Department of Veteran Affairs |
| NCT04821141 | Phase 2 | Dec 31, 2021 | National Cancer Institute (NCI), University of Kansas |
| NCT04821375 | Early Phase 1 (Phase 1) | Dec 1, 2021 | University of Kansas |
| NCT05118685 | Phase 1 | Nov 13, 2021 | Fayoum University |
| NCT05464654 | N/A | Jun 23, 2021 | Hospital General Regional No. 1 IMSS, Hospital Regional 10 de Octubre, ISSSTE, Institut d'Investigacions Biomèdiques August Pi i Sunyer, National Autonomous University of Mexico, National Polytechnic Institute, Mexico, Regional Hospital October 1st |
| NCT04478305 | Phase 1 | Mar 31, 2021 | McMaster University, Pfizer, University of Western Ontario |
| NCT04379024 | Early Phase 1 (Phase 1) | Jun 1, 2020 | Breast Cancer Research Foundation, University of Kansas |
| NCT03996603 | Phase 4 | Jul 31, 2019 | University of Alabama, Birmingham |
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Kansas | Academic/Hospital | 3 | 3 | 2 | 2020 |
| Breast Cancer Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Department of Veteran Affairs | Government | 1 | 1 | 1 | 2022 |
| Fayoum University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Hospital General Regional No. 1 IMSS | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Hospital Regional 10 de Octubre, ISSSTE | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Institut d'Investigacions Biomèdiques August Pi i Sunyer | Academic/Hospital | 1 | 0 | 1 | 2021 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| National Autonomous University of Mexico | Academic/Hospital | 1 | 0 | 1 | 2021 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2021 |
| National Polytechnic Institute, Mexico | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Pfizer | For profit | 1 | 0 | 1 | 2021 |
| Regional Hospital October 1st | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Western Ontario | Academic/Hospital | 1 | 1 | 1 | 2021 |